The global Intravenous (IV) Equipment Market is expanding with the increasing use of intravenous therapies for medication delivery, fluid replacement, nutrition, and blood transfusion. Rising hospital admissions, growing prevalence of chronic and acute conditions, and increasing demand for reliable infusion solutions are supporting market development. Advances in smart infusion pumps, safety features, and connected IV technologies are further improving treatment efficiency and patient monitoring.

The Intravenous (IV) Equipment Market is expected to reach US$ 17.54 Billion by 2034 from US$ 10.82 Billion in 2025, registering a CAGR of 5.52% during 2026–2034. Intravenous equipment plays an important role in modern healthcare by enabling the controlled administration of fluids, medications, nutrients, blood products, and other therapies directly into the bloodstream. Increasing hospital admissions, growing demand for infusion therapies, the rising prevalence of chronic diseases, and continued development of infusion technologies are supporting market expansion.

What is driving the market?

The increasing use of intravenous therapy across hospitals and other healthcare settings is a major factor driving the IV Equipment Market. IV administration is widely used when patients require rapid or controlled delivery of medications, fluids, electrolytes, nutrition, or other therapeutic substances. Its importance across emergency care, surgery, oncology, intensive care, and chronic disease management continues to sustain demand for IV equipment.

Get a Sample PDF- https://www.theinsightpartners.com/sample/TIPRE00010712

The rising prevalence of chronic conditions is another important growth factor. Patients undergoing treatment for cancer, cardiovascular diseases, kidney disorders, gastrointestinal conditions, and other long-term illnesses may require repeated intravenous therapies. This creates recurring demand for infusion devices, administration sets, catheters, pumps, and associated accessories.

Growth in surgical procedures and hospital-based treatments is also supporting the market. IV equipment is routinely used during anesthesia, surgery, postoperative care, and recovery. Expansion of hospitals, specialty treatment centers, and ambulatory healthcare facilities further increases the requirement for dependable intravenous delivery systems.

Technological developments are additionally changing IV therapy. Modern infusion systems increasingly incorporate precise flow control, programmable settings, safety mechanisms, and alarm functions designed to support accurate medication delivery and reduce administration errors.

Which region leads?

North America represents an important region in the Intravenous (IV) Equipment Market, supported by advanced healthcare infrastructure, high hospital utilization, and widespread adoption of infusion technologies. The region has an established network of hospitals, specialty clinics, and home healthcare providers that use IV equipment across numerous therapeutic applications.

Europe also represents a significant market due to developed healthcare systems and continued demand for advanced medical devices. The increasing use of infusion therapy in hospitals, oncology centers, and home-care environments supports regional demand.

Asia Pacific is expected to provide significant growth opportunities as healthcare infrastructure expands and access to medical treatment improves. Increasing hospital capacity, rising healthcare expenditure, and greater adoption of modern medical technologies are supporting demand for intravenous equipment across emerging economies.

The expansion of home-based healthcare and specialty treatment centers in Asia Pacific is also creating additional opportunities for portable and user-friendly IV systems.

Which segment leads?

Infusion pumps and related administration equipment represent a central segment of the IV Equipment Market because they enable controlled and consistent delivery of fluids and medications. Infusion pumps are particularly important when precise delivery rates are required, including applications involving potent medications, nutritional therapies, and specialized treatments.

IV catheters and access devices also represent a fundamental component of the market. These products provide vascular access for administering fluids and medications and are used extensively across hospital departments, emergency care, surgery, and long-term treatment.

The increasing complexity of intravenous therapies is encouraging demand for safety-oriented equipment. Features such as dose limits, occlusion detection, air-in-line detection, alarms, and programmable delivery parameters can help healthcare professionals manage infusion processes more effectively.

Disposable IV components remain important because healthcare facilities require sterile products for individual patient use. The emphasis on infection prevention and safe administration continues to support demand for single-use administration sets, connectors, extension lines, and related products.

Which companies are prominent?

The report profiles AngioDynamics, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, C. R. Bard, Inc., Fresenius SE & Co. KGaA, ICU Medical, Inc., Moog, Inc., Smiths Medical, and Terumo Corporation as industry participants while analyzing competitive strategies and innovation developments.

The competitive environment includes companies offering IV access products, infusion pumps, administration systems, vascular devices, and related consumables. Market participants compete through product reliability, infusion accuracy, safety features, technological innovation, portfolio breadth, and distribution networks.

Companies are increasingly focusing on integrated IV therapy solutions that combine administration hardware with safety technologies and digital monitoring. Product development is also directed toward simplifying workflows and supporting healthcare professionals in managing increasingly complex infusion regimens.

Strategic collaborations, product development initiatives, geographic expansion, and improvements in manufacturing capabilities are contributing to competitive developments across the market.

What is changing in 2026?

The IV Equipment Market is increasingly shifting toward smart infusion, improved medication safety, workflow automation, and connected healthcare technologies. Hospitals are seeking equipment that can provide accurate delivery while supporting clinicians with alerts, monitoring, and easier configuration.

Smart infusion pumps are an important area of development. Connectivity and software-based capabilities can support medication libraries, dosing safeguards, data collection, and integration with broader hospital information systems. These capabilities are increasingly relevant as healthcare providers seek to reduce preventable infusion-related errors.

Home infusion therapy is another important trend. As healthcare systems seek alternatives to prolonged hospital stays, selected therapies are increasingly being delivered outside traditional inpatient settings. This creates demand for portable, convenient, and easy-to-operate IV equipment.

Manufacturers are also focusing on infection-control improvements. Needleless connectors, closed-system technologies, improved catheter designs, and other safety-oriented products are being developed to support safer IV access and administration.

What are the major investment opportunities?

Investment opportunities are expanding across smart infusion pumps, home infusion technologies, safety-focused IV access products, connected equipment, and advanced administration systems. Companies that combine reliable delivery with digital monitoring and medication-safety capabilities can address the changing needs of healthcare providers.

Smart and connected infusion systems represent an important opportunity as hospitals increasingly adopt digital healthcare infrastructure. Integration with electronic health records and hospital information systems can improve data availability and support more coordinated medication-management workflows.

Home healthcare offers another growth area. Portable infusion pumps and simplified IV systems can support treatment outside hospitals, particularly where healthcare providers seek to reduce inpatient resource utilization while maintaining appropriate clinical oversight.

Emerging markets also present opportunities as hospitals and specialty treatment facilities expand their medical-device infrastructure. Manufacturers with cost-efficient products, regional distribution networks, training capabilities, and after-sales services can address demand in these markets.

Going forward, market participants should consider infusion accuracy, patient safety, device connectivity, cybersecurity, portability, infection control, ease of use, regulatory compliance, and total operating costs when evaluating opportunities in the Intravenous (IV) Equipment Market.

Related Reports @

Infusion Pumps & Accessories Market Size, Growth & Demand by 2034

Infusion Pumps Market Size, Growth & Demand by 2034

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish